Abstract
The amount and consistency of saliva affect the retention of removable dentures and the comfort with which patients can wear them. Recently, SST (®) (Salix Saliva-Stimulating Tablet) has developed as a saliva stimulating agent for the patients with dry mouth. In this paper, efficacies of SST (®) for dry mouth were clinicaly evaluated.
The whole salivary secretion in ten minutes was analized in 8 complete denture wearers with normal salivary secretion (normal group; 77.1±7.2 yrs.) and 10 removable denture wearers who complained of dry mouth (dry mouth group; 79.0±7.1 yrs.). Then 19 removable denture wearers who complained of dry mouth (trial use group; 79.5±6.8 yrs.) were surveyed for the clinical evaluation of SST (®) by the questionnaire before and after one-week trial use of SST. (®)
The results were as follows:
1. The unstimulating whole salivary secretion in ten minutes were 0.88ml in the normal group and 0.21 ml in the dry mouth group.
2. High secretion rate was shown by taking SST (®) in both groups with statistical significant (normal group: p<0.02, dry mouth group: p<0.01).
3. In 18 of 19 subjects (trial use group) answered relief from dry mouth after one-week trial use of SST (®) .
4. The average dosage of taking SST (®) was 2.5±2.3 tablets per day.
These results suggest that SST (®) is clinicaly effective for the patients suffering from dry mouth.
